# Fabrice André

Source: https://onco.cc/people/fabrice-andre/  
OnCo record `fabrice-andre` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Breast cancer geneticist who led SOLAR-1 and the SAFIR precision-medicine trials; ESMO President 2025-2026.

## Summary

Fabrice André is Director of Research at Gustave Roussy and Professor of Medical Oncology at Paris-Saclay, and served as President of the European Society for Medical Oncology (ESMO) for 2025-2026. His specialisms are breast cancer, precision oncology and genomics-driven trials, using comprehensive genomic profiling. He leads the breast cancer genomics programme at Gustave Roussy and was principal investigator of SOLAR-1, the trial of alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer reported in the New England Journal of Medicine. He also led the SAFIR01 and SAFIR02 genomics-guided trials, with the Nature paper on SAFIR02-BREAST testing genomics to select treatment for metastatic breast cancer. His Gustave Roussy profile and PubMed listing are linked.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Director of Research, Gustave Roussy; Professor of Medical Oncology, Paris-Saclay
- Specialisms: Breast cancer; Precision oncology; Genomics-driven trials; ESMO leadership

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Fabrice_Andr%C3%A9
- Gustave Roussy: https://www.gustaveroussy.fr/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Andre%20F%5BAuthor%5D%20breast%20alpelisib

## Connected records

- cancers: [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/)
- technologies: [Comprehensive genomic profiling](https://onco.cc/technologies/cgp/)
- targets: [PIK3CA / PI3K-alpha](https://onco.cc/targets/pik3ca/)
- drugs: [Alpelisib](https://onco.cc/drugs/alpelisib/)
- institutions: [European Society for Medical Oncology (ESMO)](https://onco.cc/institutions/esmo/), [Gustave Roussy](https://onco.cc/institutions/gustave-roussy/)
- trials: [SOLAR-1](https://onco.cc/trials/solar-1/)
- key papers: [Genomic characterization of metastatic breast cancers](https://onco.cc/key-papers/paper-bertucci-metastatic-breast-genomics-nature-2019/), [Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy](https://onco.cc/key-papers/paper-park-tils-untreated-early-tnbc-ann-oncol-2019/)

---
JSON: https://onco.cc/api/v1/entities/fabrice-andre.json